Efficacy and Safety of Different Doses of Bevacizumab Combined With Pemetrexed and Platinum in First-Line Treatment of Advanced NSCLC: A Retrospective-Real World Study

Background: Bevacizumab was demonstrated to have efficacy in patients with NSCLC. However, application of different doses of bevacizumab in different clinical trials was overlooked. This study aims to investigate the effects and safety of different doses of bevacizumab in the treatment. Methods: Fro...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Chun-Hua, Yang, Feng, Jiang, Wen-Juan, Zhang, Yong-Chang, Yang, Hai-Yan, Zeng, Liang, Liu, Li, Xiong, Yi, Zeng, Fan-Xu, Wang, Zhan, Yang, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635804/
https://www.ncbi.nlm.nih.gov/pubmed/34867332
http://dx.doi.org/10.3389/fphar.2021.727102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635804/
https://www.ncbi.nlm.nih.gov/pubmed/34867332
http://dx.doi.org/10.3389/fphar.2021.727102

Ejemplares similares